Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-04-20

FDA Approved: DALFAMPRIDINE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approved Accord Healthcare Inc.'s supplemental application for dalfampridine (generic). The approval enables the marketing of a generic dalfampridine produc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dalfampridine (dalfampridine)

Snippet

SUPPL AP for DALFAMPRIDINE (DALFAMPRIDINE)